NSE IPO DRHP filing week: IFCI, New India rally up to 8%

Market buzz: NSE IPO paperwork back in focus

Shares of The New India Assurance Company and IFCI gained on Monday as reports suggested the National Stock Exchange (NSE) may file its draft red herring prospectus (DRHP) for an IPO this week. A CNBC-TV18 report said the exchange is likely to file its IPO papers this week, and other reports cited people aware of the matter saying the filing could land on June 15 or June 16. The moves showed how quickly investor positioning can shift when the market senses progress on a long-awaited listing. For IFCI, the rally also reflected its role as a proxy bet linked to NSE through an indirect holding chain. New India Assurance, a public sector insurer, also rose in trade as the broader “NSE listing” theme returned to headlines. The proposed NSE IPO is widely expected to be structured as an offer for sale (OFS), which means existing shareholders dilute their holdings while NSE does not raise fresh capital.

What drove Monday’s move in these stocks

The immediate trigger was the fresh round of media reports around NSE’s DRHP filing timeline. According to PTI, the IPO is expected to move a step closer with NSE likely to file preliminary papers with Sebi this week, citing people aware of the matter. Business Standard also reported that NSE has asked its bankers to expedite the filing, setting a target of June 15. These reports added to a steady build-up over recent sessions, with both IFCI and New India Assurance reacting to every incremental update. In New India Assurance, the stock extended gains for a second straight session following similar DRHP-related headlines. In IFCI, the reaction was sharper, consistent with its recent pattern of outsized moves on “NSE IPO buzz” days.

New India Assurance: how the stock traded

The New India Assurance Company settled at Rs 160.52 per share on NSE, up 5.05%. During the day, it climbed as much as 7.46% to Rs 164.20 per share. The stock had already been gaining for the last two trading sessions following reports on NSE’s DRHP filing. While the article context does not detail the insurer’s specific linkage to NSE, the price action on Monday aligned with the broader market focus on the exchange’s listing path. The move also highlighted how a single corporate event can pull in names that investors associate with the theme, even when the underlying exposures differ across companies.

IFCI: a sharper rally and a 52-week high

IFCI settled at Rs 89 per share, up 5.24% on Monday. Another report in the provided text said IFCI jumped 7.95% intraday to Rs 91.36 per share, marking a fresh 52-week high, amid prospects of value unlocking for current shareholders as NSE gears up to file its DRHP. The same context noted that Monday was the second straight day of gains for IFCI, after it rallied 20% last Friday on similar expectations. On June 12, 2026, IFCI was reported to have locked into a 20% upper circuit on the NSE and hit a fresh 52-week high of about Rs 84.63-Rs 84.57. The sharp move on that day was also reported to have added nearly Rs 3,800 crore to IFCI’s market capitalisation, taking it to nearly Rs 22,786 crore.

Why IFCI is seen as an NSE IPO proxy

Some reports in the provided material described the rally as a proxy play rather than a move linked to IFCI’s standalone operations. The reasoning given is the multi-layer holding structure connecting IFCI to NSE. IFCI owns a 52.86% stake in SHCIL, and SHCIL holds a 4.4% stake in NSE as per the March 2026 quarter shareholding pattern mentioned in the text. Based on this chain, the reports estimated IFCI’s effective indirect exposure to NSE at roughly 2.3% to 2.35%. That perceived exposure has made IFCI especially sensitive to developments around the NSE IPO process.

NSE IPO structure: OFS, no fresh capital

Multiple snippets in the provided text point to an IPO structure that is expected to be a pure offer for sale. The CNBC-TV18-linked line explicitly stated the proposed IPO is expected to be structured as an offer for sale, with no fresh capital being raised by the exchange. Other reports cited in the text suggested existing shareholders could dilute around 4% to 4.5% of their stake, while another line mentioned 4.5% to 5%. The same context also referenced a potential issue size of around Rs 22,000-23,000 crore, depending on market conditions and final valuations. Separately, the unlisted market was reported to be valuing NSE in the range of about Rs 4.5 lakh crore to Rs 5 lakh crore, with some commentary pointing to a possible IPO valuation target of Rs 6 lakh crore.

DRHP timing and regulatory process

A PTI report in the provided text said NSE’s board approved the proposed IPO on February 6 after receiving Sebi’s no-objection certificate (NOC). The same report added that the DRHP is likely to be filed on June 15 or June 16. Another line, citing Business Standard, said that after submitting the DRHP, the exchange will await final observations from Sebi, a process that typically takes two to three months. These steps matter because they frame the earliest potential window for the next formal milestone, even as media reports note that NSE has not officially confirmed a filing date.

Key numbers and milestones at a glance

Market impact: what investors are reacting to

The price action across IFCI and New India Assurance shows how “event-driven” trading can intensify when a long pending corporate action appears to be moving forward. For IFCI, investors are explicitly tracking the potential value of its indirect economic exposure to NSE through SHCIL. The same reports said IFCI shares have surged 69% so far in 2026 in anticipation of the public offer, highlighting how expectations have already been getting priced in. Another data point in the provided text said IFCI has gained more than 6% in one week and 38% in one month. The sharp moves also underscore that these rallies are being driven by listing-related headlines and structure, not by any new information presented about IFCI’s underlying operations.

What to watch next

The next key step is the actual DRHP filing, which reports suggest could happen in mid-June. After that, investors will likely track Sebi’s review process and the eventual clarity on the OFS size and the percentage stake that existing shareholders will dilute. Market participants will also watch whether NSE or the regulator provides any official updates that confirm timelines mentioned in media reports. Until those milestones arrive, trading in perceived proxy names may continue to react quickly to incremental headlines.